Insitro News and Activities
Presence
Insitro is a biotechnology company that uses machine learning and lab research to discover new medicines. It provides drug discovery services and therapeutic programs for pharmaceutical companies and patients with serious diseases.
Insitro products and services overview:
- Drug discovery
- Machine learning
- Cell modeling
- Therapeutic research
Revenue: ~$50 million
Employees: 300
Headquarters: South San Francisco, United States (USA)
Insitro is one of the...
Executives
View the org chart displaying its 45 main executives
Most searched biographies at Insitro
- Daphne Koller, Founder and Chief Executive Officer
- Roger Perlmutter, Independent Director
- Paul McCracken, Board Member
Popular executive movements at Insitro
- Joe Hand has joined the company as Chief People Officer (posted on February 26 2026).
Create your alert
to follow the executive moves at Insitro.
Biotechnology
Insitro has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
- NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
- Rallybio and Avenzo Therapeutics have announced they will merge (posted on June 1 2026)..
Popular contacts in Biotechnology
News
Press releases by Insitro
- insitro and Bristol Myers Squibb Collaboration Expanded with Nomination of New Targets - insitro
- insitro Completes First AI-Enabled Human Genetics Study of Brown Adipose Tissue, Shares Differentiated Targets with Anti-Obesity Effects - insitro
- insitro Appoints Joe Hand as Chief People Officer to Advance Talent Strategy for Next Stage of Development - insitro
- insitro to Acquire CombinAbleAI to Complete its Full Stack, Modality-Agnostic AI Platform for Drug Discovery and Design - insitro
- Exclusive: Bristol Myers, insitro extend research deal to find a drug for new ALS target
- insitro Extends Research Collaboration with Bristol Myers Squibb Leveraging insitro’s ChemML Discovery Platform - insitro
- insitro partners with Lilly to build first-in-kind machine learning models to advance small molecule drug discovery - insitro
- News, Publications, and Press - insitro
- News, Publications, and Press - insitro
- News, Publications, and Press - insitro
- View more press releases Close
Social media about Insitro
- Insitro on Wikipedia, Google News & Yahoo Finance
- Insitro on LinkedIn, X (Twitter) & YouTube
